Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis

JS Musuuza, L Watson, V Parmasad… - PloS one, 2021 - journals.plos.org
Introduction The recovery of other pathogens in patients with SARS-CoV-2 infection has
been reported, either at the time of a SARS-CoV-2 infection diagnosis (co-infection) or …

COVID-19 and solid organ transplantation: a review article

Y Azzi, R Bartash, J Scalea, P Loarte-Campos… - …, 2021 - journals.lww.com
The coronavirus pandemic has significantly impacted solid organ transplantation (SOT).
Early in the outbreak period, transplant societies recommended suspending living kidney …

Vaccines and therapeutics for immunocompromised patients with COVID-19

S Shoham, C Batista, YB Amor, O Ergonul… - …, 2023 - thelancet.com
The COVID-19 pandemic has disproportionately impacted immunocompromised patients.
This diverse group is at increased risk for impaired vaccine responses, progression to …

COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis of current literature

MA Raja, MA Mendoza, A Villavicencio, S Anjan… - Transplantation …, 2021 - Elsevier
Severe acute respiratory virus syndrome 2 (SARS-CoV-2) has led to a worldwide pandemic.
Early studies in solid organ transplant (SOT) recipients suggested a wide variety of …

COVID-19: characteristics and therapeutics

R Chilamakuri, S Agarwal - Cells, 2021 - mdpi.com
Novel coronavirus (COVID-19 or 2019-nCoV or SARS-CoV-2), which suddenly emerged in
December 2019 is still haunting the entire human race and has affected not only the …

COVID-19 and liver disease

JF Dufour, T Marjot, C Becchetti, H Tilg - Gut, 2022 - gut.bmj.com
Knowledge on SARS-CoV-2 infection and its resultant COVID-19 in liver diseases has
rapidly increased during the pandemic. Hereby, we review COVID-19 liver manifestations …

[HTML][HTML] COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies

JD Goldman, PC Robinson, TS Uldrick… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. COVID-19 has highly
variable disease severity and a bimodal course characterized by acute respiratory viral …

[HTML][HTML] Impact of COVID-19 in solid organ transplant recipients

L Danziger-Isakov, EA Blumberg, O Manuel… - American Journal of …, 2021 - Elsevier
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) exploded onto the world stage in early …

[HTML][HTML] Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression

BJ Langford, M So, V Leung, S Raybardhan… - Clinical Microbiology …, 2022 - Elsevier
Background The prevalence of bacterial infection in patients with COVID-19 is low, however,
empiric antibiotic use is high. Risk stratification may be needed to minimize unnecessary …

COVID-19 and corticosteroids: a narrative review

G El-Saber Batiha, AI Al-Gareeb, HM Saad… - …, 2022 - Springer
It has been reported that corticosteroid therapy was effective in the management of severe
acute respiratory syndrome (SARS) and the Middle East Respiratory Syndrome (MERS) …